These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4752676)

  • 1. A contribution to the maintenance therapy with depot neuroleptic drugs.
    Vencovský E; Peterová E; Baudis P; Janovský F
    Act Nerv Super (Praha); 1973 May; 15(2):84. PubMed ID: 4752676
    [No Abstract]   [Full Text] [Related]  

  • 2. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W
    Med Welt; 1970 Oct; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract]   [Full Text] [Related]  

  • 3. Depot neuroleptics in the treatment of acute psychoses.
    Guarneri M; Placidi GF; Cassano GB
    Encephale; 1979; 5(2):189-93. PubMed ID: 477594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT; Hoerdt HP
    Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of depot neuroleptics: clinical experience in the United States.
    Kane JM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with depot neuroleptic treatment].
    Waldmann KD; Neumann J
    Z Arztl Fortbild (Jena); 1984; 78(20):853-6. PubMed ID: 6523910
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience with a new depot neuroleptic].
    Christiani K
    Med Klin; 1969 Sep; 64(39):1761-2. PubMed ID: 5346114
    [No Abstract]   [Full Text] [Related]  

  • 9. [Direct treatment of psychotic symptoms with an incisive neuroleptic (Dapotum Acutum)].
    Bermejo E
    Rev Med Suisse Romande; 1976 Dec; 96(12):951-3. PubMed ID: 1006000
    [No Abstract]   [Full Text] [Related]  

  • 10. Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches.
    Ereshefsky L; Saklad SR; Jann MW; Davis CM; Richards A; Seidel DR
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):50-9. PubMed ID: 6143748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of treatment by Moditen Depot in outpatients' wards in the South Moravian Region (author's transl)].
    Rektor L; Blazek J
    Cesk Psychiatr; 1980; 76(6):369-75. PubMed ID: 7471277
    [No Abstract]   [Full Text] [Related]  

  • 12. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluphenazine enanthate for the difficult psychotic patient.
    Stewart AR; Lavallee B
    Dis Nerv Syst; 1969 Feb; 30(2):98-102. PubMed ID: 5774574
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of oral and injectable phenothiazines in treatment of psychotic patients.
    Yorke ET
    Dis Nerv Syst; 1967 Oct; 28(10):667-70. PubMed ID: 4860894
    [No Abstract]   [Full Text] [Related]  

  • 15. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of high doses of fluphenazine in the treatment of psychotic patients.
    Faleni RA
    Psychosomatics; 1970; 11(5):496-9. PubMed ID: 5470678
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications and modes of administration of fluphenazine enanthate].
    Fouks L; Périvier E; Houssait A; Gilbert ; Ferragus ; Lerno M
    Ann Med Psychol (Paris); 1967 Jul; 125(2):276-82. PubMed ID: 6076191
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and biological effects of fluphénazine décanoate. 35 cases].
    Borenstein P; Dumaine A; Cujo P
    Ann Med Psychol (Paris); 1970 Jul; 2(2):267-73. PubMed ID: 5475413
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of long-acting injectable Prolixin in 23 psychotic patients.
    Whittier JR; Korenyi C; Haydu GG; Goldschmidt L
    Dis Nerv Syst; 1967 Jul; 28(7 Pt 1):459-61. PubMed ID: 4951982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.